EIKN
Eikon Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.70
+3.77%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-69.1%
Return on equity
-41.3%
Return on assets
-47.1%
Return on invested capital
0.00x
Asset turnover
-$256.0M
Cash from operations
$9.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026